MannKind Corp
MNKD
#6205
Rank
โ‚ฌ0.72 B
Marketcap
2,36ย โ‚ฌ
Share price
-0.18%
Change (1 day)
-50.83%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): โ‚ฌ28.12 Million

According to MannKind Corp's latest financial reports the company's current earnings are โ‚ฌ0.31 Billion. In 2024 the company made an earning of โ‚ฌ26.42 Million, an increase over its 2023 earnings that were of -โ‚ฌ8.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ28.12 M6.44%
2024 โ‚ฌ26.42 M-394.09%
2023 -โ‚ฌ8.99 Million-88.13%
2022 -โ‚ฌ75.69 Million8%
2021 -โ‚ฌ70.09 Million40.84%
2020 -โ‚ฌ49.76 Million10.7%
2019 -โ‚ฌ44.95 Million-40.16%
2018 -โ‚ฌ75.12 Million-26.04%
2017 -โ‚ฌ0.11 Billion-193.33%
2016 โ‚ฌ0.10 B-134.11%
2015 -โ‚ฌ0.32 Billion85.72%
2014 -โ‚ฌ0.18 Billion3.6%
2013 -โ‚ฌ0.17 Billion12.79%
2012 -โ‚ฌ0.15 Billion5.58%
2011 -โ‚ฌ0.14 Billion-5.72%
2010 -โ‚ฌ0.15 Billion-22.51%
2009 -โ‚ฌ0.2 Billion-27.37%
2008 -โ‚ฌ0.27 Billion3.36%
2007 -โ‚ฌ0.26 Billion27.18%
2006 -โ‚ฌ0.2 Billion101.63%
2005 -โ‚ฌ99.02 Million50.46%
2004 -โ‚ฌ65.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ10.26 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ17.88 B 66,994.83%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚ฌ19.48 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.99 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚ฌ0.64 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚ฌ98.54 Million-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA